Clinical Features	Time to Death		AGE		KARNOFSKY.PERFORMANCE.SCORE		NEOADJUVANT.THERAPY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q
TP53	276 (87%)	40	0.38919	1	0.64913	1	0.58484	1	0.50479	1
SRC	4 (1%)	312	0.19748	1	0.62102	1	NA	NA	0.53649	1
BRCA1	12 (4%)	304	0.9574	1	0.6504	1	NA	NA	1	1
TBP	4 (1%)	312	0.32305	1	0.19148	1	NA	NA	0.14124	1
CSMD3	18 (6%)	298	0.26157	1	0.61024	1	0.28518	1	0.53	1
NF1	14 (4%)	302	0.20016	1	0.60568	1	NA	NA	0.47763	1
RB1	9 (3%)	307	0.24084	1	0.20377	1	NA	NA	0.65847	1
C9ORF171	5 (2%)	311	0.89525	1	0.12114	1	0.7465	1	0.59146	1
GABRA6	6 (2%)	310	0.81537	1	0.012089	0.496	NA	NA	0.59487	1
CDK12	9 (3%)	307	0.36665	1	0.2136	1	0.017111	0.684	0.19348	1
FAT3	19 (6%)	297	0.13926	1	0.74339	1	0.64253	1	0.21539	1
ARHGEF9	5 (2%)	311	0.071713	1	0.42793	1	NA	NA	1	1